DynPort’s clinical stage recombinant Yersinia pestis rF1V plague vaccine to benefit from FDA Orphan Drug Designation FALLS CHURCH, Va., March 8, 2017 /PRNewswire/ — CSRA Inc. (NYSE: CSRA) today announced that […]

Global pharma giant AstraZeneca (AZN) employed a man in Australia who allegedly falsified his credentials to pose as a doctor, according to reports from the Australian Broadcast Company. Shyam Acharya […]

March 8, 2017 By Mark Terry, BioSpace.com Breaking News Staff Waltham, Mass.-based XTuit Pharmaceuticals announced today that Deborah Dunsire was stepping in as president, chief executive officer, and board member. […]

Pfizer has its eyes set on a possible $100 million investment to expand a plant in Sanford, N.C. with a focus on gene therapy, according to the Triangle Business Journal. The investment would include the addition of 50 new jobs.

Serenity Pharmaceuticals announced that the U.S. FDA approved Noctiva (desmopressin acetate), the first FDA-approved therapy for nocturia.

Nearly two decades ago, the promise of precision medicine began making its mark on the pages of medical journals – along with speculation that “therapy with the right drug at the right dose in the right patient” – would define the future of medical treatment.

Concert Pharmaceuticals Inc. announced that it has signed a definitive asset purchase agreement with Vertex Pharmaceuticals Inc. under which Vertex will acquire CTP-656.

Encouraging results were reported from UNVEIL, the first trial of patients with moderate plaque psoriasis who were naïve to systemic and biologic therapy.

Healthcare marketers have this grand vision of reaching the right patient/caregiver/healthcare professional (HCP) with the right message, at the right time, in the right context.

Understand the meaning and implications of polypharmacy and the issues it causes for patient adherence; Discover policies, technologies and procedures that can eliminate or reduce the effects of polypharmacy ensuring quality outcomes; Highlight issues Pharmacist Partners, as an organization, has remedied and the technology they utilize to decrease overuse or underuse of medication